These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21458999)

  • 21. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico prediction of membrane permeability from calculated molecular parameters.
    Refsgaard HH; Jensen BF; Brockhoff PB; Padkjaer SB; Guldbrandt M; Christensen MS
    J Med Chem; 2005 Feb; 48(3):805-11. PubMed ID: 15689164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an in silico model for predicting efflux substrates in Caco-2 cells.
    Zhang L; Balimane PV; Johnson SR; Chong S
    Int J Pharm; 2007 Oct; 343(1-2):98-105. PubMed ID: 17583455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?
    Broccatelli F; Salphati L; Plise E; Cheong J; Gobbi A; Lee ML; Aliagas I
    Mol Pharm; 2016 Dec; 13(12):4199-4208. PubMed ID: 27806577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
    Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
    Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical QSAR Analysis of Passive Permeability Across Caco-2 Monolayers.
    Lanevskij K; Didziapetris R
    J Pharm Sci; 2019 Jan; 108(1):78-86. PubMed ID: 30321548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of physicochemical properties in the estimation of skin permeability: in vitro data assessment by Partial Least-Squares Regression.
    Chauhan P; Shakya M
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):481-94. PubMed ID: 20818583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.
    Shen M; Xiao Y; Golbraikh A; Gombar VK; Tropsha A
    J Med Chem; 2003 Jul; 46(14):3013-20. PubMed ID: 12825940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    Li H; Sun J; Sui X; Liu J; Yan Z; Liu X; Sun Y; He Z
    Eur J Med Chem; 2009 Apr; 44(4):1600-6. PubMed ID: 18768239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay.
    Thiel-Demby VE; Humphreys JE; St John Williams LA; Ellens HM; Shah N; Ayrton AD; Polli JW
    Mol Pharm; 2009; 6(1):11-8. PubMed ID: 19248229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration.
    Al-Fahemi JH; Cooper DL; Allan NL
    J Mol Graph Model; 2007 Oct; 26(3):607-12. PubMed ID: 17300970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
    Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
    Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a pharmacophore-based QSAR model for the prediction of CNS activity.
    Gozalbes R; Barbosa F; Nicolaï E; Horvath D; Froloff N
    ChemMedChem; 2009 Feb; 4(2):204-9. PubMed ID: 19097128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico model of drug permeability across sublingual mucosa.
    Goswami T; Kokate A; Jasti BR; Li X
    Arch Oral Biol; 2013 May; 58(5):545-51. PubMed ID: 23123066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships.
    Cheng A; Merz KM
    J Med Chem; 2003 Aug; 46(17):3572-80. PubMed ID: 12904062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.